Fabia Gamboni

4PUBLICATIONS
36CO-AUTHORS
Respiratory diseasesInnate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 20, 2022
Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19.

Steffen M Recktenwald, Greta Simionato, Marcelle G M Lopes

|Feb 26, 2022
Specialized interferon action in COVID-19.

Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan

|Mar 02, 2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.

Isak W Tengesdal, Dinoop R Menon, Douglas G Osborne

|Jan 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.

Carlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni

Pageof 1